Diffuse large B-cell and peripheral T-cell non-Hodgkin's lymphoma in the frail elderly. A phase II EORTC trial with a progressive and cautious treatment emphasizing geriatric assessment

Journal of Geriatric Oncology

Volumn 2, Issue 1, 2011, Pages 36-44

  Soubeyran, Pierre ^a,b   Khaled, Hussein ^c   MacKenzie, Marius ^d   Debois, Muriel ^e   Fortpied, Catherine ^e   de Bock, Robrecht ^f   Ceccaldi, Joel ^g   de Jong, Daphne ^h   Eghbali, Houchingue ^a   Rainfray, Muriel ^b,i   Monnereau, Alain ^a   Zulian, Gilbert ^j   Teodorovic, Ivana ^e  

^a INSTITUT BERGONIÉ   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c NATIONAL CANCER INSTITUTE   (Egypt)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^e EORTC DATA CENTER   (Belgium)

^f MIDDELHEIM HOSPITAL   (Belgium)

^g CENTRE HOSPITALIER   (France)

^h NETHERLANDS CANCER INSTITUTE   (Netherlands)

ⁱ BORDEAUX UNIVERSITY HOSPITAL   (France)

^j GENEVA UNIVERSITY HOSPITALS   (Switzerland)

more..

Author keywords

Frail elderly; Geriatric assessment; Lymphoma; Quality of life

Indexed keywords

CYCLOPHOSPHAMIDE; PREDNISONE; VINCRISTINE;

AGED; ALOPECIA; ANOREXIA; ARTICLE; BLOOD TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CANCER MORTALITY; CANCER SURVIVAL; CARDIOTOXICITY; CHEMOTHERAPY INDUCED EMESIS; COMORBIDITY; CONSTIPATION; CONTROLLED CLINICAL TRIAL; COUGHING; DAILY LIFE ACTIVITY; DEPRESSION; DISEASE SEVERITY; DIZZINESS; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG ERUPTION; DRUG FATALITY; DRUG FEVER; DRUG MEGADOSE; DRUG SAFETY; DRUG WITHDRAWAL; DYSPNEA; EDEMA; ELDERLY CARE; FATIGUE; FEBRILE NEUTROPENIA; FEMALE; FRAIL ELDERLY; FUNCTIONAL STATUS; GASTROINTESTINAL INFECTION; GASTROINTESTINAL TOXICITY; GERIATRIC ASSESSMENT; HUMAN; HYPERTENSION; HYPOTENSION; LARGE CELL LYMPHOMA; LEUKOCYTE; LUNG TOXICITY; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; MOTOR DYSFUNCTION; MULTICENTER STUDY; MULTIPLE CYCLE TREATMENT; NAUSEA; NEPHROTOXICITY; NEUROTOXICITY; NEUTROPENIA; NEUTROPHIL; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PERIPHERAL T CELL LYMPHOMA; PHASE 2 CLINICAL TRIAL; PLEURA EFFUSION; PNEUMONIA; PROGRESSION FREE SURVIVAL; QUALITY OF LIFE; SENSORY DYSFUNCTION; SIDE EFFECT; SKIN EXFOLIATION; SKIN TOXICITY; SURVIVAL TIME; THROMBOCYTE; UROGENITAL TRACT DISEASE;

EID: 78650413827     PISSN: 18794068     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jgo.2010.08.006     Document Type: Article

References (30)

1. D'Amore F., Brincker H., Christensen B.E., Thorling K., Pedersen M., Nielsen J.L., et al. Non-Hodgkin's lymphoma in the elderly. A study of 602 patients aged 70 or older from a Danish population-based registry. The Danish LYEO-Study Group. Ann Oncol 1992, 3:379-386.
2. Maartense E., Hermans J., Kluinnelemans J.C., Kluin P.M., Vandeijk W.A., Snijder S., et al. Elderly patients with non-Hodgkin's lymphoma: population-based results in the Netherlands. Ann Oncol 1998, 9:1219-1227.
3. Bastion Y.B., Blay J.Y., Divine M., Brice P., Bordessoule D., Sebban C., et al. Elderly patients with aggressive non-Hodgkin's lymphoma: disease presentation, response to treatment, and survival. A groupe d'Etude des Lymphomes de l'Adulte study on 453 patients older than 69years. J Clin Oncol 1997, 15:2945-2953.
4. Fisher R.I., Gaynor E.R., Dahlberg S., Oken M.M., Grogan T.M., Mize E.M., et al. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. N Engl J Med 1993, 328:1002-1006.
5. Sonneveld P., Deridder M., Vanderlelie H., Nieuwenhuis K., Schouten H.L., Mulder A., et al. Comparison of doxorubicin and mitoxantrone in the treatment of elderly patients with advanced diffuse non-Hodgkin's lymphoma using CHOP versus CNOP chemotherapy. J Clin Oncol 1995, 13:2530-2539.
6. Tirelli U., Errante D., Van Glabbeke M., Teodorovic I., Kluin-Nelemans J.C., Thomas J., et al. CHOP is the standard regimen in patients >or =70years of age with intermediate-grade and high-grade non-Hodgkin's lymphoma: results of a randomized study of the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Study Group. J Clin Oncol 1998, 16:27-34.
7. Coiffier B., Lepage E., Briere J., Herbrecht R., Tilly H., Bouabdallah R., et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 2002, 346:235-242.
8. Pettengell R., Linch D. Position paper on the therapeutic use of rituximab in CD20-positive diffuse large B-cell non-Hodgkin's lymphoma. Br J Haematol 2003, 121:44-48.
9. Sehn L.H., Donaldson J., Chhanabhai M., Fitzgerald C., Gill K., Klasa R., et al. Introduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia. J Clin Oncol 2005, 23:5027-5033.
10. Soubeyran P., Eghbali H., Cany L., Ceccaldi J., Balzon J.C., Rémuzon P., et al. Intermediate and high-grade non-hodgkin's lymphomas in the elderly. Prospective registration study in a regional lymphoma network. Blood 1999, 94(Suppl. 1):524a.
11. Hoerni B., Sotto J.J., Eghbali H., Sotto M.F., Hoerni-Simon G., Pegourie B. Non-Hodgkin's malignant lymphomas in patients older than 80. 70 cases. Cancer 1988, 61:2057-2059.
12. Monfardini S., Aversa S.M., Zoli V., Salvagno L., Bianco A., Bordonaro R., et al. Vinorelbine and prednisone in frail elderly patients with intermediate-high grade non-Hodgkin's lymphomas. Ann Oncol 2005, 16:1352-1358.
13. Visani G., Ferrara F., Alesiani F., Ronconi S., Catarini M., D'adamo F., et al. R-COMP 21 for frail elderly patients with aggressive B-cell non-Hodgkin lymphoma: a pilot study. Leuk Lymphoma 2008, 49:1081-1086.
14. Harris N.L., Jaffe E.S., Diebold J., Flandrin G., Muller-Hermelink H.K., Vardiman J., et al. The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November, 1997. Ann Oncol 1999, 10:1419-1432.
15. Cheson B.D., Horning S.J., Coiffier B., Shipp M.A., Fisher R.I., Connors J.M., et al. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. J Clin Oncol 1999, 17:1244-1253.
16. Folstein M.F., Folstein S.E., McHugh P.R. Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975, 12:189-198.
17. Lawton M.P., Brody E.M. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 1969, 9:179-186.
18. Katz S., Ford A.B., Moskowitz R.W., Jackson B.A., Jaffe M.W. Studies of illness in the aged. The index of ADL a standardized measure of biological and psychosocial function. JAMA 1963, 185:914-919.
19. Sheikh J., Yesavage J.A. Geriatric Depression Scale (GDS). Recent evidence and development of a shorter version. Clin Gerontol 1986, 5:165-171.
20. Yesavage J.A. Geriatric Depression Scale. Psychopharmacol Bull 1988, 24:709-711.
21. Extermann M., Overcash J., Lyman G.H., Parr J., Balducci L. Comorbidity and functional status are independent in older cancer patients. J Clin Oncol 1998, 16:1582-1587.
22. Aaronson N.K., Ahmedzai S., Bergman B., Bullinger M., Cull A., Duez N.J., et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993, 85:365-376.
23. Extermann M. Measurement and impact of comorbidity in older cancer patients. Crit Rev Oncol Hematol 2000, 35:181-200.
24. Pfreundschuh M., Trumper L., Kloess M., Schmits R., Feller A.C., Rube C., et al. Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: results of the NHL-B2 trial of the DSHNHL. Blood 2004, 104:634-641.
25. Thieblemont C., Grossoeuvre A., Houot R., Broussais-Guillaumont F., Salles G., Traulle C., et al. Non-Hodgkin's lymphoma in very elderly patients over 80years. A descriptive analysis of clinical presentation and outcome. Ann Oncol 2008, 19:774-779.
26. Robertson R.G., Montagnini M. Geriatric Failure to Thrive. Am Fam Physician 2004, 70:343-350.
27. Sarkisian C.A., Lachs M.S. "Failure to Thrive" in Older Adults. Ann Intern Med 1996, 124:1072-1078.
28. Tucci A., Ferrari S., Bottelli C., Borlenghi E., Drera M., Rossi G. A comprehensive geriatric assessment is more effective than clinical judgment to identify elderly diffuse large cell lymphoma patients who benefit from aggressive therapy. Cancer 2009, 115:4547-4553.
29. Osby E., Hagberg H., Kvaloy S., Teerenhovi L., Anderson H., Cavallin-Stahl E., et al. CHOP is superior to CNOP in elderly patients with aggressive lymphoma while outcome is unaffected by filgrastim treatment: results of a Nordic Lymphoma Group randomized trial. Blood 2003, 101:3840-3848.
30. Batist G., Ramakrishnan G., Rao C.S., Chandrasekharan A., Gutheil J., Guthrie T., et al. Reduced cardiotoxicity and preserved antitumor efficacy of liposome-encapsulated doxorubicin and cyclophosphamide compared with conventional doxorubicin and cyclophosphamide in a randomized, multicenter trial of metastatic breast cancer. J Clin Oncol 2001, 19:1444-1454.